These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16282258)

  • 21. Examination of the effects of financial risk on the formal treatment costs for a Medicaid population with psychiatric disabilities.
    Jones K; Chen HJ; Jordan N; Boothroyd RA; Ramoni-Perazzi J; Shern DL
    Med Care; 2006 Apr; 44(4):320-7. PubMed ID: 16565632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential mental health needs of US adult residents under different provisions of the Affordable Care Act.
    Tsai J; Pilver CE; Hoff RA
    J Clin Psychiatry; 2014 Dec; 75(12):1402-10. PubMed ID: 25271598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Has the increase in HMO enrollment within the Medicaid population changed the pattern of health service use and expenditures?
    Kirby JB; Machlin SR; Cohen JW
    Med Care; 2003 Jul; 41(7 Suppl):III24-III34. PubMed ID: 12865724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of general medical services among Medicaid patients with severe and persistent mental illness.
    Salsberry PJ; Chipps E; Kennedy C
    Psychiatr Serv; 2005 Apr; 56(4):458-62. PubMed ID: 15812097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care utilization and costs among patients treated for bipolar disorder in an insured population.
    Simon GE; Unützer J
    Psychiatr Serv; 1999 Oct; 50(10):1303-8. PubMed ID: 10506298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk adjustment alternatives in paying for behavioral health care under Medicaid.
    Ettner SL; Frank RG; McGuire TG; Hermann RC
    Health Serv Res; 2001 Aug; 36(4):793-811. PubMed ID: 11508640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Carving out" conditions from global capitation rates: protecting high-cost patients, physicians, and health plans in a managed care environment.
    Maguire AM; Powe NR; Starfield B; Andrews J; Weiner JP; Anderson GF
    Am J Manag Care; 1998 Jun; 4(6):797-806. PubMed ID: 10181066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
    Barsky AJ; Orav EJ; Bates DW
    Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost and outcomes of community-based care for the seriously mentally ill.
    Dickey B; Fisher W; Siegel C; Altaffer F; Azeni H
    Health Serv Res; 1997 Dec; 32(5):599-614. PubMed ID: 9402903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicaid Expenditures for Fee-for-Service Enrollees with Behavioral Diagnoses: Findings from a 50 State Claims Analysis.
    Ward MC; Lally C; Druss BG
    Community Ment Health J; 2017 Jan; 53(1):1-7. PubMed ID: 27306989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of community-based mental health programs by HMOs: evidence from a Medicaid demonstration.
    Christianson JB; Lurie N; Finch M; Moscovice IS; Hartley D
    Am J Public Health; 1992 Jun; 82(6):790-6. PubMed ID: 1585957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicaid managed care and the distribution of societal costs for persons with severe mental illness.
    Shern DL; Jones K; Chen HJ; Jordan N; Ramoni-Perazzi J; Boothroyd RA
    Am J Psychiatry; 2008 Feb; 165(2):254-60. PubMed ID: 18198269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicaid managed care: the last bastion of the HMO?
    Draper DA; Hurley RE; Short AC
    Health Aff (Millwood); 2004; 23(2):155-67. PubMed ID: 15046139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
    Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
    Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.